CIK 0001574094 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
RenovoRx, Inc.
Sign in to watch- Ticker
- RNXT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 271448452
- Phone
- 408-800-2649
- Business address
- 2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW, CA, 94040
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-16 | Agah Ramtin Chief Medical Officer | Gift | +975,000 | 975,000 | ||
| 2022-03-10 | RYAN UNA S Director | Grant or award · Stock Option (right to buy) | +4,582 | 4,582 | ||
| 2022-03-10 | Marton Laurence Director | Grant or award · Stock Option (right to buy) | +4,582 | 4,582 | ||
| 2022-03-10 | Macfarlane K. Angela Director | Grant or award · Stock option (right to buy) | −4,582 | 4,582 | ||
| 2022-03-10 | Diamond David Director | Grant or award · Stock Option (right to buy) | +4,582 | 4,582 | ||
| 2022-03-10 | Diamond David Director | Grant or award · Stock Option (right to buy) | +9,165 | 9,165 | ||
| 2022-03-10 | Agah Ramtin Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | −21,398 | 21,398 | ||
| 2022-03-10 | Bagai Shaun Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +48,313 | 48,313 | ||
| 2022-03-03 | RYAN UNA S Director | Other acquisition | +47,789 | $4.19 | $200K | 47,789 |
| 2022-03-03 | RYAN UNA S Director | Other acquisition | +6,332 | $3.95 | $25K | 54,121 |
| 2021-10-01 | RYAN UNA S Director | Grant or award · Stock Option (right to buy) | +11,154 | 11,154 | ||
| 2021-10-01 | Marton Laurence Director | Grant or award · Stock Option (right to buy) | +11,154 | 11,154 | ||
| 2021-10-01 | Macfarlane Kirsten Angela Director | Grant or award · Stock Option (right to buy) | +11,154 | 11,154 | ||
| 2021-10-01 | Diamond David Director | Grant or award · Stock Option (right to buy) | +22,307 | 22,307 | ||
| 2021-10-01 | Diamond David Director | Grant or award · Stock Option (right to buy) | +11,154 | 33,461 | ||
| 2021-09-30 | Agah Ramtin Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +52,203 | 52,203 | ||
| 2021-09-30 | Bagai Shaun Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +117,866 | 117,866 | ||
| 2021-08-30 | Agah Ramtin Chief Medical Officer | Conversion | +1,295 | 976,295 | ||
| 2021-08-30 | Agah Ramtin Chief Medical Officer | Conversion · Convertible Notes | −1,295 | 0 | ||
| 2021-08-30 | Agah Ramtin Chief Medical Officer | Conversion · Warrants (right to buy) | +1,295 | 1,295 |
Page 6 of 6 · 120 trades